Article
Combining host-derived biomarkers with patient characteristics improves signature performance in predicting tuberculosis treatment outcomes
9 Jul 2020
Abstract excerpt
Tuberculosis (TB) is a global health concern. Treatment is prolonged, and patients on anti-TB therapy (ATT) often experience treatment failure for various reasons. There is an urgent need to identify signatures for early detection of failure and initiation of a treatment switch.We investigated how gene biomarkers and/or basic patient characteristics could be used to define signatures for treatment outcomes in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
